Ibrutinib Adapted to Response in Patients With CLL

Clinical trial NCT05360758 · UNKNOWN

Trial details

NCT number: NCT05360758
Sponsor: Grupo Argentino de Tratamiento de la Leucemia Aguda
Status: UNKNOWN
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2023-06-01
Primary completion: 2025-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.